News
Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter
26-May-2026 | 07:38
Sales rise 0.05% to Rs 237.61 crore
Net profit of Orchid Pharma rose 6.68% to Rs 23.78 crore in the quarter ended March 2026 as against Rs 22.29 crore during the previous quarter ended March 2025. Sales rose 0.05% to Rs 237.61 crore in the quarter ended March 2026 as against Rs 237.48 crore during the previous quarter ended March 2025.
For the full year,net profit declined 79.38% to Rs 20.55 crore in the year ended March 2026 as against Rs 99.66 crore during the previous year ended March 2025. Sales declined 12.00% to Rs 811.33 crore in the year ended March 2026 as against Rs 921.93 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 237.61 | 237.48 | 0 | 811.33 | 921.93 | -12 |
| OPM % | 11.31 | 11.78 | - | 5.07 | 12.71 | - |
| PBDT | 31.11 | 27.97 | 11 | 63.04 | 130.11 | -52 |
| PBT | 22.25 | 19.09 | 17 | 27.59 | 95.56 | -71 |
| NP | 23.78 | 22.29 | 7 | 20.55 | 99.66 | -79 |
Powered by Capital Market - Live News
